Canada Goose (NYSE:GOOS) Upgraded to Equal Weight at Wells Fargo & Company

Canada Goose (NYSE:GOOS - Get Free Report) was upgraded by investment analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating in a research report issued to clients and investors on Wednesday,Finviz reports.

Other equities research analysts also recently issued reports about the company. Evercore ISI decreased their target price on Canada Goose from $13.00 to $10.00 and set an "in-line" rating on the stock in a research report on Monday, February 10th. Barclays reissued an "underweight" rating and issued a $8.00 target price (down from $10.00) on shares of Canada Goose in a report on Monday, March 31st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $10.20.

Canada Goose Stock Down 1.9 %

NYSE GOOS opened at $8.16 on Wednesday. Canada Goose has a 12 month low of $6.73 and a 12 month high of $14.75. The company has a current ratio of 2.01, a quick ratio of 1.14 and a debt-to-equity ratio of 0.81. The stock has a market cap of $789.94 million, a PE ratio of 15.69, a P/E/G ratio of 1.00 and a beta of 1.32. The stock's 50 day moving average is $8.61 and its 200 day moving average is $9.57.

Canada Goose (NYSE:GOOS - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.10 earnings per share for the quarter, hitting analysts' consensus estimates of $1.10. Canada Goose had a net margin of 5.47% and a return on equity of 22.49%. Research analysts predict that Canada Goose will post 0.7 EPS for the current fiscal year.

Institutional Trading of Canada Goose

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Patient Capital Management LLC increased its position in Canada Goose by 3.4% during the fourth quarter. Patient Capital Management LLC now owns 3,854,520 shares of the company's stock valued at $38,661,000 after acquiring an additional 128,133 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in Canada Goose during the 4th quarter valued at about $12,251,000. Scheer Rowlett & Associates Investment Management Ltd. raised its position in Canada Goose by 1.2% in the 4th quarter. Scheer Rowlett & Associates Investment Management Ltd. now owns 1,218,326 shares of the company's stock worth $12,223,000 after purchasing an additional 14,341 shares during the period. Penn Capital Management Company LLC bought a new stake in Canada Goose in the fourth quarter worth about $5,702,000. Finally, Portolan Capital Management LLC purchased a new position in shares of Canada Goose during the fourth quarter valued at approximately $4,403,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

About Canada Goose

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.